ASLAN Pharmaceuticals
A clinical-stage immunology focused biopharmaceutical company.
Singapore
44 employees
IPO
Total: $218.00M
Biotechnology, Health Care +1
General Information
Singapore
BounceWatch is an independent company data service, not affiliated with ASLAN Pharmaceuticals. To contact ASLAN Pharmaceuticals, visit aslanpharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ASLAN Pharmaceuticals compare?
A PDF of ASLAN Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ASLAN Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Singapore Market
Biotechnology
About ASLAN Pharmaceuticals
Business keywords: biopharmaceutical, immunology, clinical-stage, eblasakimab, IL-13 receptor, atopic dermatitis, farudodstat, alopecia areata, drug development, clinical trials, innovation, biomedical research, pharmaceutical company, medical treatment
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $12.00M | - |
|
01 Apr 2024 |
| Private Placement VC | $20.00M | 2 |
|
01 Feb 2023 |
| Debt Financing | $45.00M | 1 |
|
01 Jul 2021 |
| Private Placement VC | $18.00M | - |
|
01 Feb 2021 |
| Post-IPO Equity | $15.00M | - |
|
01 Dec 2019 |
| IPO | $42.00M | - |
|
01 May 2018 |
| Series D | $23.00M | 2 |
|
01 Jul 2016 |
| Series C | $9.00M | 3 |
|
01 Jan 2016 |
| Series B | $22.00M | 2 |
|
01 Oct 2013 |
| Series A | $12.00M | 1 |
|
01 Jul 2011 |
ASLAN Pharmaceuticals Alternatives & Competitors
View All Alternatives
ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patien...
Alphyn develops first-in-class, multi-target therapeutics for atopic dermatitis & other severe and c...
-logo.jpg "Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)"){kind=logo}
Delivering meaningful innovation in medical dermatology.
Concert Pharmaceuticals, Inc.
VYNE Therapeutics Inc.
Cara Therapeutics
FAQ About ASLAN Pharmaceuticals
Source: BounceWatch company record for ASLAN Pharmaceuticals, https://bouncewatch.com/company/aslan-pharmaceuticals, updated 29 September 2026. When citing, please name BounceWatch and link this page.
